Correlation Between Auctus Alternative and Neurotech International

Can any of the company-specific risk be diversified away by investing in both Auctus Alternative and Neurotech International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Auctus Alternative and Neurotech International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Auctus Alternative Investments and Neurotech International, you can compare the effects of market volatilities on Auctus Alternative and Neurotech International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Auctus Alternative with a short position of Neurotech International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Auctus Alternative and Neurotech International.

Diversification Opportunities for Auctus Alternative and Neurotech International

-0.07

Correlation Coefficient

Auctus Alternative  Neurotech International

Good diversification

The 3 months correlation between Auctus and Neurotech is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Auctus Alternative Investments and Neurotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurotech International and Auctus Alternative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Auctus Alternative Investments are associated (or correlated) with Neurotech International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurotech International has no effect on the direction of Auctus Alternative i.e., Auctus Alternative and Neurotech International go up and down completely randomly.

Pair Corralation between Auctus Alternative and Neurotech International

Assuming the 90 days trading horizon Auctus Alternative Investments is expected to under-perform the Neurotech International. But the stock apears to be less risky and, when comparing its historical volatility, Auctus Alternative Investments is 1.38 times less risky than Neurotech International. The stock trades about 0.0 of its potential returns per unit of risk. The Neurotech International is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  7.20  in Neurotech International on October 10, 2024 and sell it today you would lose (1.90) from holding Neurotech International or give up 26.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.6%
Values	Daily Returns

Auctus Alternative Investments  vs.  Neurotech International

Auctus Alternative

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Auctus Alternative Investments are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Auctus Alternative may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Neurotech International

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neurotech International are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable forward indicators, Neurotech International is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Auctus Alternative and Neurotech International

The main advantage of trading using opposite Auctus Alternative and Neurotech International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Auctus Alternative position performs unexpectedly, Neurotech International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurotech International will offset losses from the drop in Neurotech International's long position.

The idea behind Auctus Alternative Investments and Neurotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.